Editorials

By: Dr. Brian Hurley While CDC’s report of a provisional 3% drop in overdose deaths last year is good news, the recent article “ Has Fentanyl Peaked?” in The New York Times had me asking a different question: How much do we care about Americans with addiction, dying at unprecedented numbers from an increasingly lethal drug supply? In his article, Mr. Lopez points out that...

EDITORIAL: APH Disparities in Overdose Deaths: Looking Back at Larochelle and Colleagues’ 2021 Paper By Nora D. Volkow, MD, Beth Han, PhD, MD, MPH, and Redonna K Chandler, PhD About the Authors: All authors are with the National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD. The opioid overdose crisis, initially most heavily affecting non-Hispanic...

Aug 14, 2023 by Brian Hurley , MD, MBA, FAPA, DFASAM President, American Society of Addiction Medicine In the time of the worst overdose crisis in American history, those of us who work in the field of addiction medicine have the responsibility of bringing treatment to where patients with addiction are. The addiction treatment gap refers to the approximately 94% of people with one or more...

Guest Editorial: Remove Arbitrary Barrier to Evidence-based Treatment for Stimulant Use Disorder by David E. Smith, MD, DFASAM Although the current overdose crisis in the US is almost universally referred to as the “opioid” or “fentanyl crisis”1,2, the overdose death rate associated with psychomotor stimulants, including methamphetamine and cocaine, has also dramatically increased in...

Guest Editorial: How Much Do We Care?

Disparities in Overdose Deaths: Looking Back at Larochelle and Colleagues’ 2021 Paper

Guest Editorial: The Future of Addiction Treatment Lies in Narrowing the Treatment Gap

Remove Arbitrary Barrier to Evidence-based Treatment for Stimulant Use Disorder

The Georgia Society of Addiction Medicine